Latest data shows the largest indicative borrow rate increases among liquid option names include: Galectin Therapeutics (GALT) 64.20% +3.11, ...
"TRITON FUNDS recognizes Bioxytran’s steadfast commitment to advancing its core thesis on the potential of Galectin Antagonists and eagerly anticipates the outcomes of upcoming trials.”, said Axel ...
It has been shown that the ß-galactoside binding lectin galectin-3 can promote fibrosis through altering cellular responses to TGFß. 1 However, the precise mechanism of this is currently unknown.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
Contributors All authors have made substantial contributions to all of the following: (1) the conception and design of the study ... Bristol-Myers Squibb, Eli Lilly, Galectin Therapeutics, Galmed ...
NORCROSS, Ga., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the top-line ...
Geneos Wealth Management Inc. raised its stake in Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent disclosure with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback